Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome-Reference-Cited by-同舟云学术

Antithrombotic efficacy of bivalirudin compared to unfractionated heparin during percutaneous coronary intervention for acute coronary syndrome

Published:2017-11-27 Issue:1 Volume:30 Page:105-111
ISSN:0953-7104
Container-title:Platelets
language:en
Short-container-title:Platelets

Author:

Frere Corinne¹²,Laine Marc³⁴,Lemesle Gilles⁵,Morange Pierre-Emmanuel¹⁶,Paganelli Franck³,Dignat-George Francoise²,Resseguier Noemie⁷,Guieu Regis⁸,Camoin-Jau Laurence¹,Bonello Laurent²³⁴

Affiliation:

1. Service d’hématologie Biologique, Centre hospitalo-universitaire Timone, Marseille, France

2. Aix-Marseille Université, INSERM UMR-S 1076, Vascular Research Center of Marseille, Marseille, France

3. Service de cardiologie, Centre hospitalo-universitaire, Aix-Marseille université, Marseille, France

4. MARS cardio, Mediterraneen Association for research and studies in cardiology, Marseille, France

5. Département de cardiologie, Centre hospitalo-universitaire de Lille, Lille, France

6. Aix-Marseille Université, INSERM UMR1062, INRA UMR1260, Nutrition, Obesity and Risk of Thrombosis, Marseille, France

7. Aix-Marseille Université, Department of Biostatistics, Marseille, France

8. Research Unit of Physiology and Pathophysiology in Extreme Oxygenation Conditions (UMR MD2), Faculty of Medicine, Aix-Marseille University, Marseille, France

Funder

AstraZeneca

Publisher

Informa UK Limited

Subject

Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/09537104.2017.1384541

Reference26 articles.

1. Bivalirudin Is a Dual Inhibitor of Thrombin and Collagen-Dependent Platelet Activation in Patients Undergoing Percutaneous Coronary Intervention

2. Platelet function and coagulation in patients with STEMI and peri-interventional clopidogrel plus heparin vs. prasugrel plus bivalirudin therapy (BRAVE 4 substudy)

3. Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome

4. Bivalirudin during Primary PCI in Acute Myocardial Infarction

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis;Cardiology Journal;2023-11-09

2. Timing of Heparin Administration Modulates Arterial Occlusive Thrombotic Response in Rats;Journal of Cardiovascular Development and Disease;2020-03-18

3. Response to the letter to the editor: anticoagulant activity of bivalirudin;Expert Opinion on Pharmacotherapy;2019-05-15

4. Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention;Thrombosis and Haemostasis;2018-06-04